Cargando…

Effective Oral Favipiravir (T-705) Therapy Initiated after the Onset of Clinical Disease in a Model of Arenavirus Hemorrhagic Fever

BACKGROUND: Lassa and Junín viruses are the most prominent members of the Arenaviridae family of viruses that cause viral hemorrhagic fever syndromes Lassa fever and Argentine hemorrhagic fever, respectively. At present, ribavirin is the only antiviral drug indicated for use in treatment of these di...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mendenhall, Michelle, Russell, Andrew, Smee, Donald F., Hall, Jeffery O., Skirpstunas, Ramona, Furuta, Yousuke, Gowen, Brian B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3191123/ https://www.ncbi.nlm.nih.gov/pubmed/22022624 http://dx.doi.org/10.1371/journal.pntd.0001342

Ejemplares similares

T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections
por: Furuta, Yousuke, et al.
Publicado: (2009)

Treatment of Late Stage Disease in a Model of Arenaviral Hemorrhagic Fever: T-705 Efficacy and Reduced Toxicity Suggests an Alternative to Ribavirin
por: Gowen, Brian B., et al.
Publicado: (2008)

Favipiravir (T-705) Inhibits Junín Virus Infection and Reduces Mortality in a Guinea Pig Model of Argentine Hemorrhagic Fever
por: Gowen, Brian B., et al.
Publicado: (2013)

Efficacy of Favipiravir (T-705) in Rabies Postexposure Prophylaxis
por: Yamada, Kentaro, et al.
Publicado: (2016)

Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase
por: FURUTA, Yousuke, et al.
Publicado: (2017)

Favipiravir (T-705) protects against Nipah virus infection in the hamster model
por: Dawes, Brian E., et al.
Publicado: (2018)

Development of a New Tacaribe Arenavirus Infection Model and Its Use to Explore Antiviral Activity of a Novel Aristeromycin Analog
por: Gowen, Brian B., et al.
Publicado: (2010)

Evaluation of Antiviral Efficacy of Ribavirin, Arbidol, and T-705 (Favipiravir) in a Mouse Model for Crimean-Congo Hemorrhagic Fever
por: Oestereich, Lisa, et al.
Publicado: (2014)

Efficacy of T-705 (Favipiravir) in the Treatment of Infections with Lethal Severe Fever with Thrombocytopenia Syndrome Virus
por: Tani, Hideki, et al.
Publicado: (2016)

Severe fever with thrombocytopenia syndrome (SFTS) treated with a novel antiviral medication, favipiravir (T-705)
por: Song, Rui, et al.
Publicado: (2019)

Broad Spectrum Antiviral Activity of Favipiravir (T-705): Protection from Highly Lethal Inhalational Rift Valley Fever
por: Caroline, Amy L., et al.
Publicado: (2014)

Differential Immune Responses to Hemorrhagic Fever-Causing Arenaviruses
por: Mantlo, Emily, et al.
Publicado: (2019)

Understanding the clinical utility of favipiravir (T-705) in coronavirus disease of 2019: a review
por: Srinivasan, Kritika, et al.
Publicado: (2021)

Structural basis for receptor recognition by New World hemorrhagic fever arenaviruses
por: Abraham, Jonathan, et al.
Publicado: (2010)

Pathogenic Mechanisms Involved in the Hematological Alterations of Arenavirus-induced Hemorrhagic Fevers
por: Schattner, Mirta, et al.
Publicado: (2013)

Hemorrhagic Fever-Causing Arenaviruses: Lethal Pathogens and Potent Immune Suppressors
por: Brisse, Morgan E., et al.
Publicado: (2019)

The broad-spectrum antiviral favipiravir protects guinea pigs from lethal Lassa virus infection post-disease onset
por: Safronetz, David, et al.
Publicado: (2015)

Transferrin receptor 1 in the zoonosis and pathogenesis of New World hemorrhagic fever arenaviruses
por: Choe, Hyeryun, et al.
Publicado: (2011)

Biochemical Reconstitution of Hemorrhagic-Fever Arenavirus Envelope Glycoprotein-Mediated Membrane Fusion
por: Thomas, Celestine J., et al.
Publicado: (2012)

Serological Assays Based on Recombinant Viral Proteins for the Diagnosis of Arenavirus Hemorrhagic Fevers
por: Fukushi, Shuetsu, et al.
Publicado: (2012)

Animal Models for the Study of Rodent-Borne Hemorrhagic Fever Viruses: Arenaviruses and Hantaviruses
por: Golden, Joseph W., et al.
Publicado: (2015)

Use of Favipiravir to Treat Lassa Virus Infection in Macaques
por: Rosenke, Kyle, et al.
Publicado: (2018)

Corrigendum to “Animal Models for the Study of Rodent-Borne Hemorrhagic Fever Viruses: Arenaviruses and Hantaviruses”
por: Golden, Joseph W., et al.
Publicado: (2015)

Identification and characterization of potent small molecule inhibitor of hemorrhagic fever New World arenaviruses
por: Bolken, Tove′ C., et al.
Publicado: (2006)

Favipiravir (T-705) Protects IFNAR(−/−) Mice against Lethal Zika Virus Infection in a Sex-Dependent Manner
por: Matz, Keesha, et al.
Publicado: (2021)

Vaccine-elicited receptor-binding site antibodies neutralize two New World hemorrhagic fever arenaviruses
por: Clark, Lars E., et al.
Publicado: (2018)

Human Hemorrhagic Fever Causing Arenaviruses: Molecular Mechanisms Contributing to Virus Virulence and Disease Pathogenesis
por: Shao, Junjie, et al.
Publicado: (2015)

The Ambiguous Base-Pairing and High Substrate Efficiency of T-705 (Favipiravir) Ribofuranosyl 5′-Triphosphate towards Influenza A Virus Polymerase
por: Jin, Zhinan, et al.
Publicado: (2013)

Clinical Management of Argentine Hemorrhagic Fever using Ribavirin and Favipiravir, Belgium, 2020
por: Veliziotis, Ioannis, et al.
Publicado: (2020)

The Janus Kinase Inhibitor Ruxolitinib Prevents Terminal Shock in a Mouse Model of Arenavirus Hemorrhagic Fever
por: Sahin, Mehmet, et al.
Publicado: (2021)

Arenaviruses.
por: Casals, J.
Publicado: (1975)

Arenaviruses
por: Gonzalez, J. P., et al.
Publicado: (2007)

Use of Recombinant Adenovirus Vectored Consensus IFN-α to Avert Severe Arenavirus Infection
por: Gowen, Brian B., et al.
Publicado: (2011)

Chapare Virus, a Newly Discovered Arenavirus Isolated from a Fatal Hemorrhagic Fever Case in Bolivia
por: Delgado, Simon, et al.
Publicado: (2008)

Genetic Detection and Characterization of Lujo Virus, a New Hemorrhagic Fever–Associated Arenavirus from Southern Africa
por: Briese, Thomas, et al.
Publicado: (2009)

Favipiravir: Drug fever: case report
Publicado: (2021)

Phase 2a, open-label, dose-escalating, multi-center pharmacokinetic study of favipiravir (T-705) in combination with oseltamivir in patients with severe influenza
por: Wang, Yeming, et al.
Publicado: (2020)

Arenavirus Budding
por: Urata, Shuzo, et al.
Publicado: (2011)

The safety profile of favipiravir should not be the first argument to suspend its evaluation in viral hemorrhagic fevers
por: Malvy, Denis, et al.
Publicado: (2020)

Clinical effect and antiviral mechanism of T-705 in treating severe fever with thrombocytopenia syndrome
por: Li, Hao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tbnf7t0gp0kpsqbgshp1g3savb